Want to join the conversation?
$STX 4Q15 Call: Non-GAAP OpEx was $515MM, reflecting expense control around the core business and new adjacencies in addition to lower variable compensation. CapEx was in line with expectations. Inventory levels were reduced 8% sequentially and STX exited 4Q15 with the lowest level of HDD finished goods inventory value since 2009.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.